Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00320528 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

269

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG: atomoxetine

Sponsor

Eli Lilly and Company